At a glance
- Originator Shionogi
- Class Antivirals
- Mechanism of Action Viral fusion protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 07 Oct 1999 New profile
- 07 Oct 1999 Preclinical development for Influenza virus infections in Japan (unspecified route)